MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -107.72% | -- | -- | -- | |
| Total Depreciation and Amortization | -17.55% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3,024.27% | -- | -- | -- | |
| Change in Net Operating Assets | -318.79% | -- | -- | -- | |
| Cash from Operations | -75.27% | -- | -- | -- | |
| Capital Expenditure | 38.57% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -303.33% | -- | -- | -- | |
| Cash from Investing | -300.07% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 93,777.89% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 65.79% | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -129.27% | -- | -- | -- | |
| Cash from Financing | 297.95% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 120.40% | -- | -- | -- | |